MedChemExpress Europe


Compounds


# Catalog Number IUPAC
201. HY-108585A 6-nitro-2-{[(6-nitro-1H-1,3-benzodiazol-2-yl)methoxy]methyl}-1H-1,3-benzodiazole
202. HY-108593 3-[(5-chloro-2-hydroxyphenyl)methyl]-5-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1,3,4-oxadiazol-2-one
203. HY-108597 3-(2H-1,3-benzodioxol-5-yl)-N-[(1S)-1-phenylethyl]-[1,2]oxazolo[5,4-c]pyridin-5-amine
204. HY-108599 8-{2-[(2-pentylcyclopropyl)methyl]cyclopropyl}octanoic acid
205. HY-108606 8-(4-aminophenyl)-2-(morpholin-4-yl)-4H-chromen-4-one
206. HY-108613 4-[bis(2H-1,3-benzodioxol-5-yl)methyl]-1-(1H-1,2,4-triazole-1-carbonyl)piperidine
207. HY-10862 N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]-1-(thiophene-2-sulfonyl)piperidine-4-carboxamide
208. HY-108628 3-(2,4-dimethyl-5-{[(3Z)-2-oxo-6-phenyl-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrol-3-yl)propanoic acid
209. HY-10863 (5Z,8Z,11Z,14Z)-N-(2-hydroxyethyl)icosa-5,8,11,14-tetraenamide
210. HY-108630 1-(6-{[(1S,11aS)-7-methoxy-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]amino}hexyl)pyrrolidine-2,5-dione
211. HY-108634 3-[7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0²,⁶]trideca-2(6),4,7,10,12-pentaen-4-yl]-1-(morpholin-4-yl)propan-1-one
212. HY-108637 [(9-ethyl-9H-carbazol-3-yl)methyl](methyl)amine
213. HY-108637A [(9-ethyl-9H-carbazol-3-yl)methyl](methyl)amine hydrochloride
214. HY-108642B 2-{[(2S)-2-amino-3-phenylpropyl]amino}-3-methyl-5-(naphthalen-2-yl)-6-(pyridin-4-yl)-3,4-dihydropyrimidin-4-one dihydrochloride
215. HY-108573 (Z)-N-cyano-N'-(2-methylbutan-2-yl)-N''-(pyridin-3-yl)guanidine
216. HY-108586 1-[4-bromo-2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]-3-[3-(trifluoromethyl)phenyl]urea
217. HY-108599A methyl 8-{2-[(2-pentylcyclopropyl)methyl]cyclopropyl}octanoate
218. HY-108643 4-{2'-fluoro-[1,1'-biphenyl]-4-yl}-N-(4-hydroxyphenyl)butanamide
219. HY-108645 3-{3-tert-butyl-6,8-difluoro-[1,2,4]triazolo[4,3-a]pyridin-7-yl}-N-cyclopropyl-5-fluoro-4-methylbenzamide
220. HY-10865 5-({[1,1'-biphenyl]-4-yl}methyl)-N,N-dimethyl-1H-1,2,3,4-tetrazole-1-carboxamide
221. HY-108677 (2R)-2-amino-N-[(1R,4R)-7,7-dimethyl-1-({[4-(2-methylphenyl)piperazin-1-yl]sulfonyl}methyl)bicyclo[2.2.1]heptan-2-yl]-4-methanesulfonylbutanamide hydrochloride
222. HY-108688 N-({3'-methanesulfonyl-[1,1'-biphenyl]-4-yl}methyl)-2,4,6-trimethyl-N-{[5-(trifluoromethyl)furan-2-yl]methyl}benzene-1-sulfonamide
223. HY-108690 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(E)-(methoxyimino)methyl]-2-methylbenzamide
224. HY-108696 3-[7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1,2,3,4-tetrahydroquinolin-1-yl]-N-methyl-1-(oxan-4-yl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carboxamide
225. HY-108697 3-{[(1S)-7-difluoromethanesulfonyl-2,2-difluoro-1-hydroxy-2,3-dihydro-1H-inden-4-yl]oxy}-5-fluorobenzonitrile
226. HY-108697A 3-[(7-difluoromethanesulfonyl-2,2-difluoro-1-hydroxy-2,3-dihydro-1H-inden-4-yl)oxy]-5-fluorobenzonitrile
227. HY-108699 4-(2-chloro-4-fluorophenyl)-3-methyl-1-(9H-purin-6-yl)-1H,4H,5H,6H,7H-pyrazolo[3,4-b]pyridin-6-one
228. HY-10870 4-amino-1-[(2R,3S,4S,5R)-5-azido-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one
229. HY-108702 [(1R,2S,4R)-4-[(5-{1-[(3-bromophenyl)methyl]-1H-pyrazole-3-carbonyl}pyrimidin-4-yl)amino]-2-hydroxycyclopentyl]methyl sulfamate
230. HY-108703A N-[(4E)-6-[3-(morpholin-4-yl)propyl]-2-{thieno[3,2-c]pyridin-6-yl}-4H-chromen-4-ylidene]hydroxylamine hydrochloride
231. HY-108705 2-{[6-({5-chloro-2-[(3R,5S)-3,5-dimethylpiperidin-1-yl]pyrimidin-4-yl}amino)-1-methyl-2-oxo-1,2-dihydroquinolin-3-yl]oxy}-N-methylacetamide
232. HY-108708 N-[2-(9H-carbazol-1-yl)phenyl]acetamide
233. HY-108709 4-{[4-(cyclopentyloxy)-5-(2-methyl-1,3-benzoxazol-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino}-3-methoxy-N-methylbenzamide
234. HY-10871 1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]-4-(ethylamino)piperidine-4-carboxamide
235. HY-108710 (7R)-2-{[(5-chloropyridin-2-yl)oxy]methyl}-5-(2-fluoropyridin-3-yl)-7-methyl-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazin-4-one
236. HY-108712 tris(1,3-dichloropropan-2-yl) phosphate
237. HY-108714 N-(5-ethyl-2,4-dimethylphenyl)-4-[3-fluoro-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1,3-thiazol-2-amine
238. HY-108715 2-[(2E)-3-[7-(azetidin-1-yl)-2-oxo-2H-chromen-3-yl]-N-(carboxymethyl)-2-cyanoprop-2-enamido]acetic acid
239. HY-108715A (acetyloxy)methyl 2-[(2E)-N-{2-[(acetyloxy)methoxy]-2-oxoethyl}-3-[7-(azetidin-1-yl)-2-oxo-2H-chromen-3-yl]-2-cyanoprop-2-enamido]acetate
240. HY-10871A 1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]-4-(ethylamino)piperidine-4-carboxamide hydrochloride
241. HY-10873 N-[2-(ethylamino)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide
242. HY-108730 methane
243. HY-108741A acetic acid; methane
244. HY-108742A methane; trifluoroacetic acid
245. HY-10875 5-({2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]phenyl}amino)-2,9-dimethyl-2,4,6,9-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
246. HY-108817 4-amino-N-[(2,4-difluorophenyl)methyl]-1-hydroxy-6-(5-hydroxypentyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide
247. HY-10882 1-[(2-chlorophenyl)diphenylmethyl]-1H-imidazole
248. HY-108820 4-amino-6-[2-(benzenesulfonyl)ethyl]-N-[(2,4-difluorophenyl)methyl]-1-hydroxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide
249. HY-108829 methane
250. HY-108847 methane


 
2020 MolPort, v3.33, release date 22-01-2020 14:00 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.